English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
时长
全部
短(小于 5 分钟)
中(5-20 分钟)
长(大于 20 分钟)
日期
全部
过去 24 小时
过去一周
过去一个月
去年
清晰度
全部
低于 360p
360p 或更高
480p 或更高
720p 或更高
1080p 或更高
源
全部
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
价格
全部
免费
付费
重置
安全搜索:
中等
严格
中等(默认)
关闭
筛选器
最匹配的结果
EyeCon 2024: Program co-chair Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
8 个月之前
ophthalmologytimes.com
ASCRS 2024: George O. Waring IV, MD, shares early results of bilateral implantation with novel IOL technology
9 个月之前
ophthalmologytimes.com
Real World Ophthalmology: A day packed with insights, innovation, and awards
2023年9月20日
ophthalmologytimes.com
Visus Therapeutics CEO announces acquisition of ViewPoint Therapeutics to expand on cataract, presbyopia candidate
2022年9月30日
ophthalmologytimes.com
Absolute Contraindications to Intravitreal Injection and Managing Patients With Contraindications
2022年7月27日
ophthalmologytimes.com
Phase 3 LUGANO Trial explores EYP-1901’s potential to reduce treatment burden in wet AMD Patients
2 个月之前
ophthalmologytimes.com
2:20
ASCRS 2024: What advancements in Light Adjustable Lens technology mean for clinicians and patients
9 个月之前
ophthalmologytimes.com
Retina Society 2024: Advances in AMD therapy highlight different mechanisms of action with a common goal
4 个月之前
ophthalmologytimes.com
(VLOG) NeuroOp Guru: Can a dead nerve swell?
3 天之前
ophthalmologytimes.com
Carl Zeiss Meditec to acquire Acri.Tec AG
2007年9月4日
ophthalmologytimes.com
AAO 2023: Neurotech's encapsulated cell therapy, NT-501
2023年11月9日
ophthalmologytimes.com
AAO 2024: Energy drinks and central retinal vein occlusions
3 个月之前
ophthalmologytimes.com
Snowmass Retina and Eye 2025: Ronald Frenkel, MD, previews interactive learning and innovation amid winter fun
1 周前
ophthalmologytimes.com
ASRS 2024: Results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
6 个月之前
ophthalmologytimes.com
Promising non-surgical treatment for early cataracts: Insights from a Phase II clinical trial
2 个月之前
ophthalmologytimes.com
Mixing and Matching Monofocal Plus IOLs with Other Advanced Technology IOLs
5 个月之前
ophthalmologytimes.com
Patient Case #1: 58-year-old patient with open angle glaucoma utilizing minimally invasive glaucoma surgery procedure
2022年6月30日
ophthalmologytimes.com
Anthony Wallace of Bausch Lomb talks about enVista Envy FDA approval
3 个月之前
ophthalmologytimes.com
Key Considerations for Selecting a Premium Intraocular Lens
2023年10月10日
ophthalmologytimes.com
ASRS 2024: Neurotech Pharmaceuticals update on the NT-501 device
6 个月之前
ophthalmologytimes.com
Trukera Medical rebranding allows team to expand into the broader corneal health market
2022年10月11日
ophthalmologytimes.com
Patient case 1: Neovascular AMD Patient Treated with Ranibizumab Biosimilar
11 个月之前
ophthalmologytimes.com
ARVO 2024: A study on multi-ingredient oral supplement for dry eye symptoms and tear volume
8 个月之前
ophthalmologytimes.com
Retina Society 2024: Population pharmacokinetic modeling and simulation of ocular clearance of aflibercept 8 mg and 2 mg
4 个月之前
ophthalmologytimes.com
Chris Brittain of Genentech discusses FDA approval to relaunch Susvimo
6 个月之前
ophthalmologytimes.com
Perspectives on Latest Therapies: Faricimab and Aflibercept 8mg
3 个月之前
ophthalmologytimes.com
MOA of Faricimab and 2-Year Data Review
2022年8月30日
ophthalmologytimes.com
AAO 2023: OTT166 progress: OcuTerra's diabetic retinopathy treatment
2023年11月3日
ophthalmologytimes.com
AGS 2024: Glaucoma management is all about the patient
10 个月之前
ophthalmologytimes.com
Overview of Biosimilars for Treating Retinal Diseases
2023年11月28日
ophthalmologytimes.com
观看更多视频
反馈